Biotech Giants Find Cooperation More Lucrative

Law360, New York (January 18, 2006, 12:00 AM EST) -- In a rare move for a litigious industry, biotechnology firm Dow Chemical Co. has reached a wide-ranging settlement and cross-licensing agreement with rival Monsanto Co., triggering what both companies hope will be profitable cooperation in emerging gene technology.

“Our business strategy is built on a commitment to broadly license our technology and compete in the marketplace,” Monsanto said in a statement.

The global business agreement is being billed as a boon to consumers by both multinational firms, which are touting the deal as a new phase...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.